Wellgistics Health, Inc. WGRX
We take great care to ensure that the data presented and summarized in this overview for Wellgistics Health, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in WGRX
Top Purchases
Top Sells
About WGRX
Insider Transactions at WGRX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 21
2025
|
Shafaat Pirani Chief Clinical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+25.53%
|
-
|
|
Mar 21
2025
|
Surendra K Ajjarapu Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,200,000
+14.03%
|
-
|
|
Mar 21
2025
|
Surendra K Ajjarapu Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,882,247
+61.27%
|
-
|
|
Mar 21
2025
|
Sajid Syed Director |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+44.97%
|
-
|
|
Mar 21
2025
|
Donald William Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+44.97%
|
-
|
|
Mar 21
2025
|
Prashant Patel Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
2,200,000
+50.0%
|
-
|
|
Mar 21
2025
|
Prashant Patel Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,882,247
+31.37%
|
-
|
|
Mar 21
2025
|
Brian Norton Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,000,000
+49.88%
|
-
|
|
Mar 21
2025
|
Nikul Panchal Chief Pharmacy Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
90,000
+50.0%
|
-
|
|
Mar 21
2025
|
Rebecca M Shanahan Director |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+44.97%
|
-
|
Last 12 Months Summary
Buy / Acquisition
17.9M
Shares
From
8
Insiders
| Grant, award, or other acquisition | 17.9M shares |
|---|
Sell / Disposition
0
Shares
From
0
Insiders